Delpazolid (LCB01-0371) is under investigation in clinical trial NCT01554995 (A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.